Dashboard
Manage Tickers

STRRPSTAR EQUITY HOLDINGS, INC.

Nasdaq starequity.com


$ 9.36 $ 0.15 (1.58 %)    

Thursday, 05-Sep-2024 14:44:06 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 453.22 $ 0.69 (0.15 %)
DIA $ 408.27 $ 0.95 (0.23 %)
SPY $ 544.94 $ 0.27 (0.05 %)
TLT $ 99.50 $ 0.13 (0.13 %)
GLD $ 230.88 $ -0.38 (-0.16 %)
$ 9.67
-- x --
-- x --
-- - --
$ 8.02 - $ 11.70
608
na
13.87M
$ -0.06
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-20-2024 03-31-2024 10-Q
3 03-22-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-11-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-15-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-12-2022 06-30-2022 10-Q
10 05-23-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-10-2021 06-30-2021 10-Q
14 05-14-2021 03-31-2021 10-Q
15 03-29-2021 12-31-2020 10-K
16 11-13-2020 09-30-2020 10-Q
17 08-13-2020 06-30-2020 10-Q
18 05-15-2020 03-31-2020 10-Q
19 03-09-2020 12-31-2019 10-K
20 11-14-2019 09-30-2019 10-Q
21 08-13-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 03-01-2019 12-31-2018 10-K
24 11-05-2018 09-30-2018 10-Q
25 08-03-2018 06-30-2018 10-Q
26 05-07-2018 03-31-2018 10-Q
27 02-28-2018 12-31-2017 10-K
28 11-03-2017 09-30-2017 10-Q
29 08-04-2017 06-30-2017 10-Q
30 05-01-2017 03-31-2017 10-Q
31 02-28-2017 12-31-2016 10-K
32 10-31-2016 09-30-2016 10-Q
33 08-01-2016 06-30-2016 10-Q
34 05-02-2016 03-31-2016 10-Q
35 03-01-2016 12-31-2015 10-K
36 11-02-2015 09-30-2015 10-Q
37 08-07-2015 06-30-2015 10-Q
38 05-01-2015 03-31-2015 10-Q
39 03-06-2015 12-31-2014 10-K
40 10-31-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION